2 September 2026
ASPEN PHARMACARE HOLDINGS LIMITED - Reviewed Condensed Group Financial Results for the year ended 30 June 2026 and Cash Dividend Declaration

2 September 2026
ASPEN PHARMACARE HOLDINGS LIMITED - General repurchase of ordinary shares

21 August 2026
ASPEN PHARMACARE HOLDINGS LIMITED - Business update and trading statement for the year ended 30 June 2026

3 August 2026
ASPEN PHARMACARE HOLDINGS LIMITED - Notice regarding the Release of Aspens Financial Results for the year ending 30 June 2026, and Results Presentation

20 July 2026
ASPEN PHARMACARE HOLDINGS LIMITED - Health Canada approves Aspen-Semaglutide